Unlinked ECGs and Untracked Cardiac Risk: The Gaps in Paper Cardiology — and How CARDIS Fixes Them

Quick answer: On paper, ECG traces and echo reports are filed away from the patient record, cardiovascular risk factors are never tracked over time, and cardiac medications stay invisible to other clinicians. The harm is real: rising risk goes untreated, prior tests are lost so nothing can be compared, and dangerous gaps open in care. CARDIS, the OPES Cardiology Information System, closes every one of these gaps.

Key facts

• Comparing a current ECG to a patient's prior ECGs is central to cardiology — a change between tracings is often the finding itself. On paper, those prior tracings are usually lost.
• Cardiovascular disease is a leading cause of death worldwide and is rising across Africa, which makes tracking risk factors over time essential rather than optional.
• Framingham and the ESC (European Society of Cardiology) scores are widely recognised cardiovascular-risk tools; CARDIS computes them from data already in the record.
• CARDIS provides three core modules — ECG Management, Echocardiography Reporting, and Cardiovascular Risk — all integrated with the OPES EMR so cardiac results and plans are visible to every clinician.
• Echo reporting in CARDIS uses ASE/EACVI measurement templates, the same standards cardiologists already work with.

Why does paper-based cardiology lose critical information?

Cardiology generates documents that only have value when they stay connected to the patient. An ECG strip, an echocardiography report, a catheterisation finding — each one means something specific in the context of a particular patient, on a particular date, against everything that came before. On paper, that connection is exactly what breaks.

The ECG is printed and slipped into a folder, or handed to the patient, or pinned to a chart that later goes missing. The echo report is dictated, typed, and stored wherever the cardiology office keeps its files — rarely in the same place as the rest of the record. The risk factors that drive cardiovascular disease, such as blood pressure, lipids, body-mass index, and HbA1c, are written down at each visit and never assembled into a trend. Each piece exists; none of them talk to each other.

The result is a record that cannot answer the questions cardiology actually asks. Has this patient's risk been climbing for three years? Is today's ECG different from last year's? What cardiac drugs is this patient on right now? On paper, every one of those answers requires digging — and often the documents needed to answer simply cannot be found.

What harm comes from unlinked ECGs and untracked cardiac risk?

The first harm is rising risk that no one is managing. When blood pressure, lipids, BMI, and HbA1c are scattered across visit notes instead of tracked as trends, a slow, dangerous climb is invisible. Cardiovascular disease is a leading cause of death worldwide and is rising in Africa, and much of that burden is driven by exactly this kind of unmanaged, accumulating risk — risk that, seen early, is treatable, and that leads to preventable heart attacks and strokes when it is not.

The second harm is the lost baseline. Comparison is at the heart of cardiology: a new ECG is read against the patient's prior tracings, and the change is frequently the finding itself. When prior ECGs and echoes are filed away or lost, the cardiologist is left interpreting today's test in isolation, with nothing to compare it against. A subtle but important change — the kind that signals a developing problem — can pass unnoticed simply because the earlier tracing is gone.

The third harm is hidden cardiac medications. A patient on anticoagulants, beta-blockers, or antiarrhythmics carries a critical safety profile, and when those drugs live only in the cardiology file, the clinicians treating that patient elsewhere — in the emergency room, in surgery, on a ward — cannot see them. That blind spot creates real danger: contraindicated prescriptions, missed interactions, and decisions made without the full picture.

How does CARDIS solve these cardiology gaps?

CARDIS — the OPES Cardiology Information System — is built around dedicated cardiology workflows: ECG, echo reports, cardiac catheterisation, and long-term cardiovascular risk management. It replaces the scattered paper trail with one structured, connected cardiology record.

ECG Management. CARDIS imports digital ECGs and stores them against the patient record, where they stay. Interpretation is captured with structured templates rather than free-text scrawl, so findings are consistent and searchable. Most importantly, CARDIS lets the cardiologist compare a current ECG across visits — the prior tracings are right there — restoring the baseline that paper destroys. Critical-finding alerts flag tracings that need urgent attention so they are not lost in a queue.

Echocardiography Reporting. CARDIS provides echo reporting built on ASE/EACVI measurement templates, with image annotation, so reports are complete and standardised. Each finished report flows into the OPES EMR, ending the era of the echo report that lives in a separate office no one else can reach.

Cardiovascular Risk. This is where CARDIS turns scattered numbers into a managed picture. It tracks blood pressure, lipids, BMI, and HbA1c as trends, and it computes recognised risk scores — Framingham and ESC — from the data already in the record. Target-achievement tracking shows, at a glance, whether a patient is reaching their goals. The whole history sits on one dashboard, from the first visit to the current one, so rising risk is visible early enough to treat.

To see how this fits the wider picture of long-term disease management, our article on chronic disease (diabetes and hypertension) management covers the same longitudinal principle applied across conditions.

How does CARDIS connect cardiac care to the rest of the record?

A cardiology system is only as useful as its connections, and CARDIS is designed to be part of the wider OPES platform rather than another island.

Every CARDIS report — ECG interpretations, echo reports, risk assessments, and care plans — flows into the OPES EMR, so a patient's cardiac picture is part of their single record, not a separate file. Through OPESCare, the cardiac medications a patient is taking become visible to every clinician who treats them, closing the dangerous gap where heart drugs are known only to the cardiology office.

CARDIS also draws on the rest of the platform. Laboratory values that cardiology depends on — lipid panels, troponin, and more — come directly from OPES Lab, so they populate the risk dashboard and the patient record without re-entry. For patients whose cardiovascular risk is bound up with diabetes, CARDIS links to ENDOIS, the OPES endocrinology system, so HbA1c and glycaemic control are shared between the two. For more on the laboratory backbone behind these values, see our overview of laboratory information systems in Cameroon.

The result is cardiology that is no longer trapped on paper: structured, comparable, longitudinal, and visible to everyone who needs it. You can learn more on the CARDIS product page.

Frequently Asked Questions

What is CARDIS?

CARDIS is the OPES Cardiology Information System — software with dedicated cardiology workflows for ECG management, echocardiography reporting, cardiac catheterisation, and long-term cardiovascular risk management. It integrates with the OPES EMR so cardiac results and plans are visible to every clinician, and it is fully bilingual (English and French).

Can CARDIS compare a patient's ECGs over time?

Yes. CARDIS imports digital ECGs, stores them against the patient record, and lets cardiologists compare a current tracing against the patient's prior ECGs across visits. Because comparison is central to cardiology, this restores the baseline that paper records routinely lose. Critical-finding alerts highlight tracings that need urgent attention.

How does CARDIS track cardiovascular risk?

CARDIS tracks blood pressure, lipids, BMI, and HbA1c as trends over time and computes recognised cardiovascular-risk scores — Framingham and ESC — from data already in the record. Target-achievement tracking and a single longitudinal dashboard, from first visit to current, make rising risk visible early enough to manage.

Are cardiac medications visible to other clinicians?

Yes. Because CARDIS reports into the OPES EMR and shares medications through OPESCare, a patient's cardiac drugs are visible to every clinician who treats them — not just the cardiology office. This closes a dangerous gap where heart medications are otherwise invisible elsewhere in the hospital.

Conclusion

Paper cardiology loses the very things that make cardiac care work: the linked test, the trend, the visible medication. The harm follows directly — untreated rising risk, lost baselines for comparison, and dangerous blind spots for other clinicians. CARDIS closes these gaps with structured ECG and echo workflows, a longitudinal cardiovascular-risk dashboard, and full integration with the OPES EMR, so cardiology becomes connected, comparable, and safe.

OPES Health Systems builds CARDIS to give Cameroonian and CEMAC hospitals cardiology workflows that link every ECG, echo, and risk factor to the patient record. Book a demo to see how CARDIS protects your cardiac patients.